1.6.7.4Vertical

Healthcare Regulatory Advisory

Consultants supporting healthcare regulatory compliance programs.

Market snapshot

These figures describe Regulatory & Compliance Consulting (1.6.7), the segment that Healthcare Regulatory Advisory sits within — not Healthcare Regulatory Advisory on its own.

FragmentationFragmentedEstimate

Specialty within management and scientific/technical consulting (NAICS 541611/541618/541690); the Census Bureau does not separately size it.

Business model & economics

Revenue model

Advisory fees with recurring compliance-program support

Key economics

Recurring revenue
Moderate

ongoing compliance relationships recur

EBITDA margin
18–30%
Capex intensity
Low

Characteristics

  • Structurally growing with the expanding regulatory burden.
  • AML, ESG, privacy, and EHS are key demand sources.
  • Recurring compliance support complements project advisory.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Risk & compliance advisory platforms
  • Consulting strategics
  • PE-backed roll-ups

What’s driving deals

  • Expanding regulation driving structural demand.
  • AML, ESG, and privacy opening new advisory niches.
  • Consolidation across risk and compliance advisory.

Find Healthcare Regulatory Advisory acquisition targets

Search Acquisera’s index for companies classified under Healthcare Regulatory Advisory (1.6.7.4) and build a targeted deal pipeline.

Search companies